BOLT Return on Tangible Equity | Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. (BOLT) Return on Tangible Equity

2026-06-30: Return Tang Equity -227.37%.
2026-03-31: Return Tang Equity -149.23%.
2025-12-31: Return Tang Equity -125.92%.
2025-09-30: Return Tang Equity -132.96%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-227.37%
2026-03-31	-149.23%
2025-12-31	-125.92%
2025-09-30	-132.96%
2025-06-30	-130.56%
2025-03-31	-135.33%
2024-12-31	-110.35%
2024-09-30	-90.36%
2024-06-30	-77.06%
2024-03-31	-60.51%
2023-12-31	-61.38%
2023-09-30	-55.58%
2023-06-30	-54.03%
2023-03-31	-51.62%
2022-12-31	-51.37%
2022-09-30	-50.55%
2022-06-30	-46.59%
2022-03-31	-42.83%
2021-12-31	-39.42%
2021-09-30	-37.27%
2021-06-30	-30.10%
2021-03-31	-25.24%
2020-12-31	57.87%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-125.92%
2024-12-31	-110.35%
2023-12-31	-61.38%
2022-12-31	-51.37%
2021-12-31	-39.42%
2020-12-31	57.87%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63
SYNLOGIC, INC. (SYBX)	United States	$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Pulmatrix, Inc. (PULM)	United States	$0.006B
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54